• Trends in utilization and clin...

Treffer: Trends in utilization and clinical outcomes with and without the use of distal filter wire embolic protection devices.

Title:
Trends in utilization and clinical outcomes with and without the use of distal filter wire embolic protection devices.
Authors:
Scully TG; Department of Cardiology, Eastern Health, Box Hill, VIC, Australia., Roberts L; Department of Cardiology, Eastern Health, Box Hill, VIC, Australia. Electronic address: Louise.Roberts@easternhealth.org.au., Dinh D; School of Public Health and Preventive Medicine (SPHPM), Monash University, Melbourne, VIC, Australia. Electronic address: diem.dinh@monash.edu., Brennan A; School of Public Health and Preventive Medicine (SPHPM), Monash University, Melbourne, VIC, Australia. Electronic address: angela.brennan@monash.edu., Clark D; University of Melbourne, Melbourne, VIC, Australia; Department of Cardiology, Austin Health, Heidelberg, VIC, Australia. Electronic address: David.CLARK@austin.org.au., Ajani A; University of Melbourne, Melbourne, VIC, Australia; Department of Cardiology, Royal Melbourne Hospital, Parkville, VIC, Australia. Electronic address: Andrew.ajani@mh.org.au., Reid CM; School of Public Health and Preventive Medicine (SPHPM), Monash University, Melbourne, VIC, Australia; School of Populations Health Curtin University, Perth, WA, Australia. Electronic address: christopher.reid@curtin.edu.au., Oqueli E; Department of Cardiology, Ballarat Health Service, Ballarat, VIC, Australia; School of Medicine, Faculty of Health, Deakin University, Geelong, VIC, Australia. Electronic address: Ernesto.oqueliFlores@bhs.org.au., Hiew C; Department of Cardiology, Barwon Health Service, Geelong, VIC, Australia. Electronic address: chin.hiew@barwonhealth.org.au., Stub D; School of Public Health and Preventive Medicine (SPHPM), Monash University, Melbourne, VIC, Australia; Department of Cardiology, Alfred Health, Prahran, VIC, Australia. Electronic address: dion.stub@monash.edu., Chandrasekhar J; Department of Cardiology, Eastern Health, Box Hill, VIC, Australia; Eastern Health Clinical School, Monash University, Clayton, VIC, Australia., Freeman M; Department of Cardiology, Eastern Health, Box Hill, VIC, Australia. Electronic address: melzabojec@gmail.com.
Source:
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2025 Aug; Vol. 77, pp. 97-101. Date of Electronic Publication: 2024 Oct 28.
Publication Type:
Journal Article; Comparative Study
Language:
English
Journal Info:
Publisher: Elsevier Country of Publication: United States NLM ID: 101238551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0938 (Electronic) Linking ISSN: 18780938 NLM ISO Abbreviation: Cardiovasc Revasc Med Subsets: MEDLINE
Imprint Name(s):
Original Publication: New York, NY : Elsevier, c2005-
MeSH Terms:
Embolic Protection Devices*/trends , Percutaneous Coronary Intervention*/adverse effects , Percutaneous Coronary Intervention*/mortality , Percutaneous Coronary Intervention*/trends , Percutaneous Coronary Intervention*/instrumentation , Saphenous Vein*/transplantation , Saphenous Vein*/diagnostic imaging , Coronary Artery Bypass*/adverse effects , Coronary Artery Bypass*/mortality , Coronary Artery Bypass*/trends , Graft Occlusion, Vascular*/mortality , Graft Occlusion, Vascular*/diagnostic imaging , Graft Occlusion, Vascular*/therapy , Graft Occlusion, Vascular*/etiology, Humans ; Male ; Female ; Aged ; Treatment Outcome ; Registries ; Time Factors ; Middle Aged ; Risk Factors ; Retrospective Studies ; Risk Assessment
Contributed Indexing:
Keywords: Embolic protection; PCI; Saphenous vein graft
Entry Date(s):
Date Created: 20241102 Date Completed: 20250808 Latest Revision: 20250808
Update Code:
20250809
DOI:
10.1016/j.carrev.2024.10.008
PMID:
39488483
Database:
MEDLINE

Weitere Informationen

Background: Embolic protection devices were developed to reduce the risk of common complications encountered during percutaneous coronary intervention (PCI) of saphenous vein grafts, however, in the setting of contemporary multi-modality medical management, their overall efficacy has been called into question. This study aimed to assess the evolving utilization and clinical outcomes associated with distal filter wire embolic protection devices in saphenous vein PCI.
Methods: Consecutive patients undergoing PCI to a saphenous vein graft in a registry were included. Peri-procedural and long-term outcomes including 12-month mortality and 30-day MACCE rates were compared between PCI using a distal filter wire embolic protection device and unprotected PCI.
Results: From 2005 to 2020, a total of 753 patients underwent PCI to a saphenous vein graft with 256 using a distal filter wire embolic protection device. At one year, the use of a distal filter wire embolic protection devices was not associated with a decrease in mortality (4.7 % vs 5.4 %, p = 0.19) and there was no difference in 30-day MACCE rates between protected and unprotected saphenous vein PCI (3.1 % vs 5.8 %, p = 0.10).
Conclusion: In this 12-month analysis of saphenous vein graft PCI, there was no evidence that distal filter wire embolic protection devices improved short term post procedural or long-term mortality outcomes.
(Copyright © 2024. Published by Elsevier Inc.)

Declaration of competing interest The authors declare that they have no competing interests.